← Back to Clinical Trials
RecruitingNCT04852198

Comparing 150cm OAGB With 150cm Biliopancreatic Limb RYGB. A Non-inferiority Trial

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionBariatric Surgery Candidate
SponsorFlevoziekenhuis
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment298
SexALL
Min Age18 Years
Max Age65 Years
Start Date2021-12-13
Completion2027-06-13
Interventions
OAGBRYGB

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The purpose of this study is to assess the safety and efficiency of OAGB compared to RYGB

Eligibility Criteria

Inclusion Criteria: * body-mass index (BMI) of 40 kg/m2 or higher, or 35 kg/m2 or higher with the presence of at least one comorbidity (type 2 diabetes, high blood pressure, obstructive sleep apnoea, dyslipidaemia, osteoarthritis of the hip or knee) * a positive evaluation by our BMDT Exclusion Criteria: * Presence of H. Pylori, resistant to eradication therapy * chronic diarrhoea * history of previous bariatric or extensive abdominal surgery

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE BARIATRIC SURGERY CANDIDATE TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology